Beijing FDA Introduces New Regs On Advertisements For Drugs, Devices, And Dietary Supplements
This article was originally published in PharmAsia News
Beijing FDA has issued a new regulation on advertising for drugs, medical devices and dietary supplements that increases the approval process for ads to five business days.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.